W. Allan Alexander

Dr. Alexander has worked for over 20 years in industry, with experience in all phases of product development from product conception, acquisition, preclinical preparation for regulatory submission, clinical trial design, execution, regulatory negotiation to results dissemination. His work focuses primarily on bridging the gap between the causes of severe bleeding and new, emerging hemostatic therapies. Prior to Cellphire, Dr. Alexander served as Vice President of Medical Affairs for HEMA Biologics, LLC and US WorldMeds, LLC, and served in similar roles at ZymoGenetics, Inc., Sangart, Inc., and CSL Behring, LLC. He previously served as an Associate Professor of Cardiovascular Anesthesiology at Baylor College of Medicine.

Dr. Alexander received his Doctor of Medicine at Texas Tech University School of Medicine and performed his residency in Cardiovascular Anesthesiology at the Texas Heart Institute at the University of Texas. He received a Bachelor of Arts in biochemistry from the University of Texas, Austin.